Aurora Cannabis Inc (ACB) |
|
11.43 -0.21 (-1.8%)
|
02-25 11:37 |
|
Open: |
11.63 |
Pre. Close: |
11.64 |
|
High:
|
11.708 |
Low:
|
11.33 |
|
Volume:
|
4,653,081 |
Market Cap:
|
2,237M |
|
|
|
|
Aurora Cannabis Inc. produces and distributes medical cannabis products worldwide. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, including facility engineering and design, cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories, including valves, screens, etc.; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and ROAR Sports. Aurora Cannabis Inc. is headquartered in Edmonton, Canada. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
11.787 - 11.853 |
11.853 - 11.913 |
|
Low:
|
10.832 - 10.916 |
10.916 - 10.992 |
|
Close:
|
11.515 - 11.64 |
11.64 - 11.755 |
|
Technical analysis |
as of: 2021-02-25 11:07:23 AM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 18.18 One year: 22.17 |
| Support: |
Support1: 10.04 Support2: 8.35 |
| Resistance: |
Resistance1: 15.56 Resistance2: 18.98 |
| Pivot: |
13.31  |
| Moving Average: |
MA(5): 11.66 MA(20): 13.01
MA(100): 9.05 MA(250): 9.90 |
| MACD: |
MACD(12,26): 0.10 Signal(9): 0.54 |
| Stochastic oscillator: |
%K(14,3): 15.02 %D(3): 14.26 |
| RSI: |
RSI(14): 46.62 |
| 52-week: |
High: 19.68 Low: 3.71 Change(%): -28.8 |
| Average Vol(K): |
3-Month: 3122503 10-Days: 2698455 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.ACB has closed above bottom band by 26.4%. Bollinger Bands are 80.7% wider than normal. The large width of the bands suggest high volatility as compared to ACB's normal range. The bands have been in this wide range for 11 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
Wed, 24 Feb 2021
Aurora Cannabis reiterated as underperform by Jefferies after earnings 'reinforce concerns on its underlying business' - MarketWatch
Wed, 24 Feb 2021
Is Aurora Cannabis Stock a Buy? - Motley Fool
Tue, 23 Feb 2021
Where Will Aurora Cannabis Be in 1 Year? - Motley Fool
Mon, 22 Feb 2021
Aurora Cannabis Inc. stock underperforms Monday when compared to competitors - MarketWatch
Thu, 18 Feb 2021
Aurora Cannabis Inc. stock falls Thursday, underperforms market - MarketWatch
Wed, 17 Feb 2021
ACB Stock News: Aurora Cannabis Inc flies high with unexpected boost from pension fund - FXStreet
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Neutral |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Neutral |
Price to Earnings: |
Underperform |
| Return on Equity: |
Neutral |
Debt to Equity: |
Neutral |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NYSE |
| Sector: Healthcare |
| Industry: Drug Manufacturers General Specialty & Generic |
| Shares Out. (M) |
197 |
| Shares Float (M) |
160 |
|
% Held by Insiders
|
0.20 |
|
% Held by Institutions
|
14.14 |
|
Shares Short (K)
|
33,220 |
|
Shares Short P. Month (K)
|
36,540 |
Stock Financials |
|
EPS
|
0.220 |
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
3.440 |
|
Profit Margin
|
|
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
-6.7 |
|
Return on Equity (ttm)
|
-103.3 |
|
Qtrly Rev. Growth
|
-8.0 |
|
Gross Profit (p.s.)
|
-0.170 |
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
|
|
Levered Free Cash Flow (M)
|
|
Stock Valuations |
|
PE Ratio
|
52.05 |
|
PEG Ratio
|
|
|
Price to Book value
|
3.33 |
|
Price to Sales
|
|
|
Price to Cash Flow
|
|
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
